I have Type 1 diabetes. I love to write. I’m happy when I am helping others. I speak up when it’s important. I have a passion for sharing knowledge and learning new technology. I was BORN to BLOG!

I’ve met so many other T1Ds on this journey who are cool and love to help others. We put our heads and hearts together … to bring more resources and knowledge to our amazing diabetes community. We’re making improvements every day … come back often, let us know what you think. And my gratitude for my amazing webmaster, Dave (an honorary T1D)!

And thank you for stopping by!
— Joanne Laufer Milo, The Savvy Diabetic

Savvy Updates, 2/7/22:  Novo Nordisk, Lilly, Novartis Accused of Price Collaboration, Double Diabetes, Beta Cell Pathway Discovered, Lighting & Lower BG, FDA & D Device Interoperability, Dr. Pettus Got Covid

Savvy Updates, 2/7/22: Novo Nordisk, Lilly, Novartis Accused of Price Collaboration, Double Diabetes, Beta Cell Pathway Discovered, Lighting & Lower BG, FDA & D Device Interoperability, Dr. Pettus Got Covid

Novo Nordisk challenges House report it collaborated with competitors on insulin prices was written by Jonathan Block for SeekingAlpha.com, 2 February 2022.   Novo Nordisk CEO Lars Joergensen struck back at a House Oversight Committee report issued in...

read more
Savvy Update, 1/24/22:  Updates from Kevin Sayer/Dexcom and John Sheridan/Tandem, Vitamin D Preserves Beta Function, DIY APS Offers Best Results, T1D Many Types?, Lyumjev Update, Mark Cuban’s CostPlus Drug Service

Savvy Update, 1/24/22: Updates from Kevin Sayer/Dexcom and John Sheridan/Tandem, Vitamin D Preserves Beta Function, DIY APS Offers Best Results, T1D Many Types?, Lyumjev Update, Mark Cuban’s CostPlus Drug Service

Dexcom CEO on G7's global launch, COVID-19 slowing new patient adds, international growth was reported by Ricky Zipp for MedTechDive.com, 18 January 2022.   After proving fairly resilient throughout the last two years, even as other medtechs were hit by...

read more
Savvy Updates, 1/17/22:  Dexcom G7 Update with Kevin Sayer, “Medical” Wearables, NAFLD & T1D, Pancreatic Exocrine Insufficiency, Stair Walking & Insulin Sensitivity

Savvy Updates, 1/17/22: Dexcom G7 Update with Kevin Sayer, “Medical” Wearables, NAFLD & T1D, Pancreatic Exocrine Insufficiency, Stair Walking & Insulin Sensitivity

Fitbit and Apple know their smartwatches aren't medical devices. But do you? was written by Lisa Eadicicco for cnet.com, 14 January 2022.  The line is blurring as wearables become more advanced. And it's only getting more complicated. The Fitbit Sense and similar...

read more
Share This
Skip to content